These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27012291)

  • 1. An Overview on Indian Patents on Biotechnology.
    Mallick A; Chandra Santra S; Samal AC
    Recent Pat Biotechnol; 2015; 9(3):198-213. PubMed ID: 27012291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual Property Rights: Protection of Biotechnological Inventions in India.
    Gomase V; Kemkar K; Potnis V
    Recent Pat Biotechnol; 2024; 18(2):128-143. PubMed ID: 38282443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotechnology and food security in the 21st century.
    Serageldin I
    Science; 1999 Jul; 285(5426):387-9. PubMed ID: 10411497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sources of innovation: an assessment of intellectual property.
    Kinch MS; Raffo J
    Drug Discov Today; 2015 May; 20(5):500-4. PubMed ID: 25499663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Innovation on Dental Products in Argentina: A Technological Prospecting Based on Patents.
    Valadas LAR; Oliveira Filho RD; Lotif MAL; Júnior FJG; Júnior EAD; Bandeira MAM; Squassi A
    Recent Pat Biotechnol; 2021; 15(1):3-11. PubMed ID: 33305714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intellectual property sharing initiative in agricultural biotechnology: development of broadly accessible technologies for plant transformation.
    Chi-Ham CL; Boettiger S; Figueroa-Balderas R; Bird S; Geoola JN; Zamora P; Alandete-Saez M; Bennett AB
    Plant Biotechnol J; 2012 Jun; 10(5):501-10. PubMed ID: 22221977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
    Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
    Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
    Malhotra P
    Indian J Med Ethics; 2008; 5(2):61-5. PubMed ID: 18624153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.
    Halliburton M
    Glob Public Health; 2009; 4(6):515-27. PubMed ID: 19548158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patents versus patenting: implications of intellectual property protection for biological research.
    Lei Z; Juneja R; Wright BD
    Nat Biotechnol; 2009 Jan; 27(1):36-40. PubMed ID: 19131994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals.
    Babovic S; Wasan KM
    J Pharm Sci; 2011 Mar; 100(3):816-21. PubMed ID: 20740678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic patent protection in the pharmaceutical and biotechnology industries.
    Nunnally AC; Webster CJ; Brown SA; Cohen GA
    Community Genet; 2005; 8(4):209-16. PubMed ID: 16244474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
    Jannuzzi AH; Vasconcellos AG; de Souza CG
    Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic crops, biotechnology and ownership rights: what scientists need to know.
    Kowalski SP; Ebora RV; Kryder RD; Potter RH
    Plant J; 2002 Aug; 31(4):407-21. PubMed ID: 12182700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the legal regime of intellectual property protection in the pharmaceutical market.
    Pashkov VM; Golovanova IA; Olefir AA
    Wiad Lek; 2016; 69(3 pt 2):582-586. PubMed ID: 27717949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intellectual property protection: strategies for antibody inventions.
    Storz U
    MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.